INTRODUCTION
The incidence of ocular metastasis from lung cancer is reported to be 2-7% according to the international literature. The majority of cases involves end-stage patients (1) . Metastatic tumors are the most common intraocular malignancies, and choroid is by far the most common site for intraocular malignancies. Multiple foci are usually involved and bilateral involvement is frequently seen (2) . The lung cancer is the first cause of choroidal metastasis in men, as the breast cancer is in women. Estimates of the incidence of intraocular metastases in patients dying from disseminated cancer range from 22,000 to 66,000 affected individuals per year in the United States (3) .
CASE PRESENTATION
A 71 year-old woman noticed, progressive vision reduction in both eyes. Ocular examination revealed her best visual acuity to be 20/40 RE (right eye) and 20/100 LE (left eye). Results of her slit lamp revealed nuclear cataract in both eyes. Her pupil size and reaction was normal. Her ocular movements were normal in all gazes. Her intraocular pressure was also normal. Fundus examination of the left eye showed an ill-defined, yellow-white elevated lesion in choroid about five times the disc diameter in size (Figure 1) . A fundus picture of the right eye was normal. An ultrasonographic evaluation of the eye demonstrated that the tumor had a height 4,1 mm, anterior-posterior length 13 mm and lateral length 12,9 mm. The tumor revealed a dome-surfaced, elevated choroidal lesion with moderated internal reflectivity. Fluorescein angiography showed hiperfluorescence from the surface of her choroidal tumor. The lesion was on its late phase and it had already accumulated subretinal fluid. Routine systemic investigation including complete blood cell count, platelet count, bleeding time, urine analysis, serum electrolytes, blood biochemical studies for hepatic and renal function was carried out A chest x-ray showed a homogenous opaque mass in patient's left hilar area. A computer tomography scan of the thorax revealed a several small nodules in both superior lobe of the lung and pleural effusions. (Figure 2). Transbronchial biopsy revealed bronchioloalveolar carcinoma (Figure 3 ). At this time the patient also showed bone metastasis. The chemotherapy was not initiated because our patient died after few weeks.
DISCUSSION
The highly vascular uveal tract is the most common part of the eye involved by metastasis. Within the uvea, the choroid (88%) is the most commonly affected site followed by the iris (9%) and ciliary body (2%). Breast cancer seems to be the most frequent type of cancer giving intraocular metastasis (4) . The incidence for breast cancer is reported to be 37 -41%, while lung cancer is considered to be responsible for no more than 7% of choroidal metastasis. Approximately 50% of suspect choroidal metastasis and no history of cancer, has no primary site detected despite systemic evaluation by oncologists. It is generally considered that this kind of metastatic lesion occur at the final stages of the disease, where the mean survival is not expected to be more than 6 months and the majority of the patients already suffer from the typical lung cancer symptoms. The reason for this unusual site to be target for secondary metastasis from lung cancer is generally unknown. It is, however speculated that is high vascularity may consist a reasonable explanation (1) . The other frequent sites of choroidal metastasis are alimentary tract cancers, prostate, skin melanoma, kidneys, contralateral choroidal melanoma, thyroid and testis (5) . To date, only 2 series describing 13 and 90 patients, respectively, with predominantly choroidal metastasis from lung cancer, have been published. Shields and et al. reported that in 56% of patients with intraocular lung cancer metastasis, the primary tumor was detected after the diagnosis of intraocular metastasis (6) . Choroidal metastasis commonly complain of loss of vision, pain and photopsia. Ophthalmic examination may reveal multiple or bilateral lesions sometimes associated with exudative retinal detachment. The typical lesion is flat and ill defined, most of the cases grey-yellow or yellow-white, with alterations of the retinal pigment epithelium. In rare cases the breaking of the Bruch membrane can lead to mushroom configuration.
The diagnosis of ocular metastasis is based primarily on clinical findings supplemented by imaging studies. The diagnostic procedures include ultrasonography, fluorescein angiography, computed tomography/MRI, fine needle aspiration, or wedge biopsy. Brain imaging is useful before initiation of radiotherapy to assist in treatment planning. It is reported that 22% of patients diagnosed with CM had a concurrent diagnosis of central nervous system metastasis. Differential diagnosis includes primary choroidal melanomas, benign lesions such as hemangioma, and inflammatory granulomas (1) . Systemic chemotherapy can lead to total involution of the CM with improvement of the visual acuity (7) . Despite systemic chemotherapy or hormone therapy the growing of the choroidal metastasis with symptomatic subretinal fluid, external beam radiation therapy or pla que raditoin therapy is recommended. A systematic search for lung cancer is required in patients presenting as CM. If compatible with the patient general status, histologically adapted chemotherapy must be instituted. This approach can avoid the use of radiotherapy and therefore deterioration of the visual acuity after radiation. However, the diagnosis of CM is associated with a poor prognosis. The initial sign of lung cancer may rarely be visual symptoms due to choroidal metastasis. In such a condition, the lung cancer is already at an advanced stage (8) . The ophthalmologist ought to be aware of the choroidal metastasis sings to its prompt recognition and appropriated treatment.
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